麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

韩琳; 吕超; 李敏; 黄慧梅; 畅婉琳; 彭成成; 柳润辉

doi:10.3969/j.issn.1006-0111.2014.03.012

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

韩琳, 吕超, 李敏, 黄慧梅, 畅婉琳, 彭成成, 柳润辉

文章导航 > 药学实践与服务 > 2014 > 32(3): 209-211,219

韩琳, 吕超, 李敏, 黄慧梅, 畅婉琳, 彭成成, 柳润辉. 麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选[J]. 药学实践与服务, 2014, 32(3): 209-211,219. doi: 10.3969/j.issn.1006-0111.2014.03.012

引用本文:

HAN Lin, LV Chao, LI Min, HUANG Huimei, CHANG Wanlin, PENG Chengcheng, LIU Runhui. Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(3): 209-211,219. doi: 10.3969/j.issn.1006-0111.2014.03.012

Citation:

HAN Lin, LV Chao, LI Min, HUANG Huimei, CHANG Wanlin, PENG Chengcheng, LIU Runhui. Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(3): 209-211,219. doi: 10.3969/j.issn.1006-0111.2014.03.012

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

1.
第二军医大学药学院, 上海 200433
2.
福建中医药大学药学院, 福建福州 350108
3.
上海交通大学药学院, 上海 200240

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

1.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China
2.
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, China
3.
School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

摘要: 目的建立原代心肌细胞缺氧-复氧模型,并对麝香保心丸及其20种血中活性成分进行抗缺氧-复氧损伤的活性筛选。方法取新生(1~3 d)SD乳鼠的心脏,建立原代心肌细胞的缺氧-复氧损伤模型,并采用四甲基偶氮唑盐(MTT)比色法进行麝香保心丸及其入血成分的活性筛选。结果麝香保心丸在50 μg/ml浓度下具有较好的保护原代心肌细胞缺氧-复氧损伤的作用;人参皂苷Rb1、人参皂苷Rb2、蟾毒灵和麝香酮具有较好的保护原代心肌细胞缺氧-复氧损伤的作用。结论麝香保心丸具有抗心肌细胞缺氧-复氧损伤的作用,人参皂苷Rb1、人参皂苷Rb2、蟾毒灵和麝香酮是其主要的有效成分。该研究为麝香保心丸深入的药效和机制研究奠定了基础。
- 麝香保心丸 /
- 心肌细胞 /
- 缺氧-复氧模型 /
- 活性成分筛选
Abstract: Objective To build hypoxia/reoxygenation injury model in cultured neonatal rat cardiomyocyte and screen active components from Shexiang Baoxin Pill (SBP) absorbed in blood against hypoxia/reoxygenation injury. Methods Cardiomyocytes were isolated and purified from hearts of neonatal Sprague Dawley rats(1~3 days old) and were used to build hypoxia/reoxygenation injury model. The components of SBP absorbed in blood were screened by methyl thiazolil tetracolium (MTT) colorimetic method. Results SBP showed significant protective effect against cardiomyocytes hypoxia/reoxygenation injury atthe concentration of 50 μg/ml. Ginsenoside Rb1, Rb2, bufalin and muscone of twenty components from SBP absorbed in blood also possessed significant protective effect against cardiomyocytes hypoxia/reoxygenation injury. Conclusion SBP have the protective activity against cardiomyocytes hypoxia/reoxygenation injury, and ginsenoside Rb1, Rb2, bufalin, muscone are the main active components of SBP. This experiment offered basis for further pharmacodynamics and mechanism study of SBP.
- Shexiang Baoxin Pill (SBP) /
- cardiomyocyte /
- hypoxia/reoxygenation model /
- screening of active components

[1]	车薇, 陈红英, 张淑珍. 麝香保心丸的临床应用研究进展[J]. 中国急救复苏与灾害医学杂志, 2008, 3(5): 307-309.
[2]	宋华. 麝香保心丸的药理研究与临床评价[J]. 中成药, 2002, 24(2): 131-133.
[3]	李修, 金胡珂, 吴国洪. 麝香保心丸治疗急性心肌梗死疗效观察[J]. 现代中西医结合杂志, 2012, 21(10): 1062-1063.
[4]	Xiang L, Jiang P, Zhan CS, et al. The serum metabolomic study of intervention effects of the traditional Chinese medicine Shexiang Baoxin pill and a multi-component medicine polypill in the treatment of myocardial infarction in rats[J]. Mol Biosyst, 2012, 8(9): 2434-2442.
[5]	Jiang P, Liu RH, Dou SS, et al. Analysis of the constituents in rat plasma after oral administration of Shexiang Baoxin pill by HPLC-ESI-MS/MS[J]. Biomed Chromatogr, 2009, 23(12): 1333-1343.
[6]	郭黎安,王淑萍, 向丽, 等. 气相色谱-质谱法定性分析麝香保心丸挥发性入血成分的研究[J]. 药学实践杂志, 2012,30(3): 207-210.
[7]	Grynberg A, Athias P, Degois M. Effect of change in growth environment on cultured myocardial cells investigated in a standardized medium[J]. In vitro Cell Dev Biol, 1986,22(1): 44-50.
[8]	张爽, 李红, 杨世杰. 蒺藜皂苷单体 B 对心肌细胞缺氧/复氧损伤的保护作用[J]. 中国药理学通报, 2010, 26(2): 208-212.
[9]	马青变, 高炜, 郭艳红, 等. 缺氧复氧诱导大鼠心肌细胞内质网应激反应[J]. 北京大学学报(医学版), 2005, 37(4): 386-388.
[10]	Kong HL, Wang JP, Li ZQ, et al. Anti-hypoxic effect of ginsenoside Rbl on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo[J]. Acta Pharmacol Sin, 2009, 30 (4): 396-403.
[11]	Kong HL, Li ZQ, Zhao YJ, et al. Ginsenoside Rb1 protects cardiomyocytes against CoCl₂-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening[J]. Acta Pharmacol Sin, 2010, 31 (6): 687-695.
[12]	Wu QB, Li HT, Wu Y, et al. Protective effects of muscone on ischemia-reperfusion injury in cardiac myocytes[J]. J Ethnopharmacol, 2011, 138 (1): 34-39.

[1]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[2]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[3]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[4]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
[5]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
[6]	杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛. 正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
[7]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[8]	杨嘉宁, 赵一颖, 肖伟. 七味脂肝方对非酒精性脂肪性肝炎动物模型的药效学评价 . 药学实践与服务, 2024, 42(9): 389-398. doi: 10.12206/j.issn.2097-2024.202404096
[9]	王鹏, 陈顺, 赵逸, 高守红, 王志鹏. 卡培他滨致小鼠手足综合征模型的建立及评价 . 药学实践与服务, 2024, 42(9): 385-388, 398. doi: 10.12206/j.issn.2097-2024.202308045
[10]	王雪莲, 郑斯莉, 李志勇, 罗亨宇, 缪朝玉. 全身过表达人METRNL基因小鼠模型的构建与验证 . 药学实践与服务, 2024, 42(5): 198-202, 222. doi: 10.12206/j.issn.2097-2024.202311014
[11]	张广雨, 杜晶, 刘梦珍, 朱丹妮, 闫慧, 刘冲. 新斯的明与山莨菪碱联合应用对肺型氧中毒的保护作用及其机制的研究 . 药学实践与服务, 2024, 42(10): 433-438, 444. doi: 10.12206/j.issn.2097-2024.202310049
[12]	陈方剑, 骆锦前, 王志君, 胡叶帅, 孙煜昕, 宋洪杰. HPLC-MS/MS同时测定感冒安颗粒中5种黄酮成分的含量 . 药学实践与服务, 2024, 42(9): 402-406. doi: 10.12206/j.issn.2097-2024.202403030
[13]	李丹, 戴贤春, 王芳珍, 陈奕含, 杨萍, 刘继勇. HPLC-MS/MS测定当归六黄汤中4种不同成分的含量 . 药学实践与服务, 2024, 42(6): 248-252, 266. doi: 10.12206/j.issn.2097-2024.202305007
[14]	赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量. 中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(5): 203-210, 216. doi: 10.12206/j.issn.2097-2024.202211012
[15]	姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量. 巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
[16]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073

点击查看大图

计量

文章访问数: 3052
HTML全文浏览量: 282
PDF下载量: 296
被引次数: 0

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

1. 第二军医大学药学院, 上海 200433

2. 福建中医药大学药学院, 福建福州 350108

3. 上海交通大学药学院, 上海 200240

收稿日期: 2014-01-15
修回日期: 2014-04-02

关键词:

摘要: 目的建立原代心肌细胞缺氧-复氧模型,并对麝香保心丸及其20种血中活性成分进行抗缺氧-复氧损伤的活性筛选。方法取新生(1~3 d)SD乳鼠的心脏,建立原代心肌细胞的缺氧-复氧损伤模型,并采用四甲基偶氮唑盐(MTT)比色法进行麝香保心丸及其入血成分的活性筛选。结果麝香保心丸在50 μg/ml浓度下具有较好的保护原代心肌细胞缺氧-复氧损伤的作用;人参皂苷Rb1、人参皂苷Rb2、蟾毒灵和麝香酮具有较好的保护原代心肌细胞缺氧-复氧损伤的作用。结论麝香保心丸具有抗心肌细胞缺氧-复氧损伤的作用,人参皂苷Rb1、人参皂苷Rb2、蟾毒灵和麝香酮是其主要的有效成分。该研究为麝香保心丸深入的药效和机制研究奠定了基础。

English Abstract

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, China

3. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

Received Date: 2014-01-15
Rev Recd Date: 2014-04-02

Keywords:

Abstract: Objective To build hypoxia/reoxygenation injury model in cultured neonatal rat cardiomyocyte and screen active components from Shexiang Baoxin Pill (SBP) absorbed in blood against hypoxia/reoxygenation injury. Methods Cardiomyocytes were isolated and purified from hearts of neonatal Sprague Dawley rats(1~3 days old) and were used to build hypoxia/reoxygenation injury model. The components of SBP absorbed in blood were screened by methyl thiazolil tetracolium (MTT) colorimetic method. Results SBP showed significant protective effect against cardiomyocytes hypoxia/reoxygenation injury atthe concentration of 50 μg/ml. Ginsenoside Rb1, Rb2, bufalin and muscone of twenty components from SBP absorbed in blood also possessed significant protective effect against cardiomyocytes hypoxia/reoxygenation injury. Conclusion SBP have the protective activity against cardiomyocytes hypoxia/reoxygenation injury, and ginsenoside Rb1, Rb2, bufalin, muscone are the main active components of SBP. This experiment offered basis for further pharmacodynamics and mechanism study of SBP.

引用本文:

Citation:

HAN Lin, LV Chao, LI Min, HUANG Huimei, CHANG Wanlin, PENG Chengcheng, LIU Runhui. Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(3): 209-211,219. doi: 10.3969/j.issn.1006-0111.2014.03.012

全文HTML

参考文献 (12)

下载: 全尺寸图片幻灯片

返回文章

用微信扫码二维码

分享至好友和朋友圈

主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

电话: （021）81871324,81871397 E-mail: [email protected]

网站备案号沪ICP备05003363号-1

本系统由北京仁和汇智信息技术有限公司开发

留言板

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

计量

出版历程

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

1. 第二军医大学药学院, 上海 200433 2. 福建中医药大学药学院, 福建 福州 350108 3. 上海交通大学药学院, 上海 200240

English Abstract

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China 2. College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, China 3. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

全文HTML

目录

1. 第二军医大学药学院, 上海 200433

2. 福建中医药大学药学院, 福建福州 350108

3. 上海交通大学药学院, 上海 200240

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, China

3. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China